Genetic variations in NADPH-CYP450 oxidoreductase in a Czech Slavic cohort

Pharmacogenomics. 2015;16(3):205-15. doi: 10.2217/pgs.14.169.

Abstract

Aim: Estimating polymorphic allele frequencies of the NADPH-CYP450 oxidoreductase (POR) gene in a Czech Slavic population.

Methods: The POR gene was analyzed in 322 individuals from a control cohort by sequencing and high resolution melting analysis.

Results: We identified seven unreported SNP genetic variations, including two SNPs in the 5' flanking region (g.4965C>T and g.4994G>T), one intronic variant (c.1899-20C>T), one synonymous SNP (p.20Ala=) and three nonsynonymous SNPs (p.Thr29Ser, p.Pro384Leu and p.Thr529Met). The p.Pro384Leu variant exhibited reduced enzymatic activities compared with wild-type.

Conclusion: New POR variant identification indicates the number of uncommon variants might be specific for each subpopulation being investigated, particularly germane to the singular role that POR plays in providing reducing equivalents to all CYP450s in the endoplasmic reticulum. Original submitted 15 September 2014; Revision submitted 17 November 2014.

Keywords: CYP; Czech Slavic population; NADPH-cytochrome; P450 oxidoreductase; P450 reductase; POR; allele frequencies; haplotype; pharmacogenetics.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Amino Acid Substitution
  • Base Sequence
  • Cohort Studies
  • Cytochrome P-450 Enzyme System / chemistry
  • Cytochrome P-450 Enzyme System / genetics*
  • Cytochrome P-450 Enzyme System / metabolism
  • Czech Republic
  • DNA / genetics
  • Female
  • Gene Frequency
  • Genetic Variation
  • Haplotypes
  • Humans
  • Infant, Newborn
  • Kinetics
  • Linkage Disequilibrium
  • Male
  • Models, Molecular
  • Mutation, Missense
  • Polymorphism, Single Nucleotide*
  • Protein Conformation

Substances

  • POR protein, human
  • DNA
  • Cytochrome P-450 Enzyme System